Early SVD has been reported in these devices, particularly three to four years after implantation. According to the FDA, this has resulted in surgical replacement procedures and transcatheter valve-in-valve interventions. In some cases, the patient died.
A) Example of a transcatheter aortic valve replacement using the Electroducer Sleeve via the left radial route. B) Example of a femoral percutaneous coronary intervention using the Electroducer Sleeve. Image courtesy of EuroIntervention and Wintzer-Wehekin et al.
Early evidence suggests the Electroducer Sleeve is safe and effective among patients presenting for certain interventional procedures.
Monthly marijuana use, meanwhile, was not associated with a greater CAD risk. The full study is scheduled to be presented at ACC.23/WCC in New Orleans.
Sahil Parikh, MD, director of endovascular services at Columbia University Irving Medical Center, said treating these patients can be quite challenging.
Alexandra Bastiany, MD, made history when she became Canada’s first Black female interventional cardiologist in 2020. Now, that achievement is being recognized in a surprising way.
“It's all about risks and benefits," one researcher said. "Starting transitioning is a big part of a person's life and helping them feel more themselves, but hormone replacement therapy also has a lot of side effects—it's not a risk-free endeavor."
The device, which gained FDA approval in 2021, was part of a voluntary recall in 2022 due to stability concerns. Medtronic worked with the FDA to address the issue, and the Harmony TPV is once again available throughout the United States.
According to a new analysis of data from nearly six million patients, experiencing long-lasting COVID-19 symptoms more than doubles the risk of cardiac complications.
